Kentucky Bioprocessing LLC has been given a $17.9 million investment award from the Defense Advanced Research Projects Agency, according to a news release from the U.S. Defense Department.
The Owensboro, Ky.-based company was among 25 firms that bid on the federal contract. The technology investment agreement calls for Kentucky Bioprocessing to develop “a proof-of-concept platform capable of yielding a purified vaccine candidate using a whole plant-based process,” the release said.
Work is expected to be completed in March 2011. Kentucky Bioprocessing is a biotechnology company that uses plant-based proteins to develop scientific processes that can advance science.